Skip to content
Home/Companies/Healthcare/Nuclidium
NU

Nuclidium

Healthcare·France·Active

Nuclidium is a healthcare company, headquartered in France.

Entry
–
Hold
–
Status
Active
Est. EV
–

Who owns Nuclidium?

Nuclidium is currently owned by Kurma Partners through Kurma Growth Opportunities (2024 vintage). Across its history, Nuclidium has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Kurma Partners
Most recent investor
Kurma Partners
Kurma Growth Opportunities · 2024 · Growth
2 ownership periods · full history below

Key facts

HQFrance
SectorHealthcare

Ownership history

2 ownership periods

Active
Co-held by DeepTech & Climate Fonds and Kurma Partners since 2025.
DeepTech & Climate Fonds
DeepTech & Climate FondsActive
2025 · present · DeepTech & Climate Fonds · 2022 · Evergreen
MOIC
–
Kurma Partners
Kurma PartnersActive
present · Kurma Growth Opportunities · 2024 · Growth
MOIC
–

More from Kurma Growth Opportunities

Other portfolio companies in the same fund.

Damae Medical
Active
HealthcareFrance
Germitec
Active
HealthcareFrance
Hopia
Active
HealthcareFrance
Pantera
Active
HealthcareFrance
Poppins
Active
TMTFrance
Shorla Oncology
Active
HealthcareFrance

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings